Brink Therapeutics is developing next-generation recombinases — ultra-precise and efficient enzymes that surpass CRISPR-Cas9. We aim to revolutionize Cell and Gene therapies, enabling large-scale production to treat cancer, genetic disorders, and other diseases.
Company Details
- Employees
- 4
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.brinktx.com
- Keywords
- Show more similar pages.
Brink Therapeutics Questions
Brink Therapeutics's website is http://www.brinktx.com
Brink Therapeutics's LinkedIn profile is https://www.linkedin.com/company/brinktx
Brink Therapeutics has
4 employees.
View email and phone details for 4
employees at Brink Therapeutics.
Brink Therapeutics's industry is
Biotechnology Research
Brink Therapeutics's top competitors are
Omogen,
Detect,
Delos,
Wavo,
Spore.bio,
Syntopia,
Corteria Pharmaceuticals,
Coave Therapeutics,
Sensebiotek Health Care,
Biohive.
Brink Therapeutics's categories are Biotechnology Research
Brink Therapeutics's founding year is 2024
